Sign Up to like & get
recommendations!
1
Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26677
Abstract: Treatment options with targeted agents have changed the treatment landscape of CLL profoundly. Besides chemoimmunotherapy, treatment regimen approved for frontline therapy include continuous treatment with BTK inhibitors like ibrutinib and acalabrutinib or fixedâduration regimen like…
read more here.
Keywords:
front line;
lymphocytic leukemia;
chronic lymphocytic;
management front ... See more keywords